Potent inhibitors of LpxC for the treatment of Gram-negative infections.
Matthew F Brown, Usa Reilly, Joseph A Abramite, Joel T Arcari, Robert Oliver, Rose A Barham, Ye Che, Jinshan Michael Chen, Elizabeth M Collantes, Seung Won Chung, Charlene Desbonnet, Jonathan Doty, Matthew Doroski, Juntyma J Engtrakul, Thomas M Harris, Michael Huband, John D Knafels, Karen L Leach, Shenping Liu, Anthony Marfat, Andrea Marra, Eric McElroy, Michael Melnick, Carol A Menard, Justin I Montgomery, Lisa Mullins, Mark C Noe, John O'Donnell, Joseph Penzien, Mark S Plummer, Loren M Price, Veerabahu Shanmugasundaram, Christy Thoma, Daniel P Uccello, Joseph S Warmus, Donn G Wishka
文献索引:J. Med. Chem. 2nd ed., 55 , 914-923, (2012)
全文:HTML全文
摘要
In this paper, we present the synthesis and SAR as well as selectivity, pharmacokinetic, and infection model data for representative analogues of a novel series of potent antibacterial LpxC inhibitors represented by hydroxamic acid.
相关化合物
相关文献:
2015-02-04
[J. Neurosci. 35(5) , 1999-2014, (2015)]
2009-01-01
[Mol. Vis. 15 , 2535-43, (2009)]
2014-12-01
[Poult. Sci. 93(12) , 3179-86, (2014)]
2007-07-01
[Antimicrob. Agents Chemother. 51 , 2445-53, (2007)]
2007-04-01
[Antimicrob. Agents Chemother. 51 , 1259-67, (2007)]